The Board of Directors
Mr Nathan Nagel, Chief Executive Officer
Nathan is a serial entrepreneur and excels in corporate strategy, organisational leadership and financial decision making. Nathan is currently serving as an executive board director to multiple companies. His executive experience includes: Interim Managing Director of the US liver disease CRO Sanyal Bio LLC, CEO of the Neuroscience Software R&D start-up Brain-e-Games Ltd, interim CEO of the Neuroscience Biotechnology company Neuro-Bio Ltd and CEO of the market research company Oncology Pharma Ltd. In parallel to leading Oncology Pharma Ltd Nathan was managing partner of LifeScience Ventures Ltd, a UK consulting company and also partner in the IoM company LifeScience Ventures fund. Prior to leading companies Nathan worked for Bayer Diagnostics and Takeda Pharmaceuticals, where he started his career. His is also a voluntary Managing Director of a Dementia Charity which the UK PM Theresa May is the ambassador of. He is currently studying towards becoming an IoD Chartered Director.
Dr Michael Gamlen, Founder and Chief Scientific Officer
Michael is a graduate with first class honours in pharmacy (specialising in pharmaceutical engineering) of Sunderland University and has a PhD from Nottingham University. At Nottingham he trained with Professor JM Newton, one of the UK’s leading tableting researchers and the first person to use tensile fracture stress measurements to evaluate tablets.
Michael spent a year at Beechams Pharmaceuticals working on a completely novel technique to instrument a rotary tablet press. He then joined Wellcome Foundation, where for 14 years he was responsible for development of all tablet formulations including hundreds of clinical trial formulations as well as licensed products (of which many are still on the market).
The Team A-Z
Anthony Clayden, Head of Finance
Anthony joined the advisory team in January 2014 and provides a strategic finance director advisory service to Gamlen Tableting Limited. He is a natural sciences graduate of Durham University and a qualified chartered accountant since 1994.
Anthony has worked in a full-time or portfolio finance director capacity for over 14 years with 20 companies from owner managed businesses through to AIM quoted companies. They have ranged from pre-revenue R and D businesses to multi-million pound services groups and covered a wide variety of industries. He focuses on unlocking the high growth potential of businesses.
Prior to becoming a finance director, he worked in corporate finance for 5 years with PwC and KPMG.
Joe Domingue, North America Sales Director
Joe has spent over 30 years in the scientific instrumentation industry spanning numerous roles including R&D chemist (Beckman Instruments), regional sales manager, product manager & director of marketing (Cahn Instruments), and independent sales & marketing consultant (SciMark International) establishing a market for Surface Measurement Systems’ novel physico-chemical characterization instruments primarily within the pharmaceutical R&D community in North America.
A graduate of the University of California, San Diego with a bachelors degree in chemistry, Joe subsequently earned an MBA from the University of California, Irvine. As product manager for Cahn Instruments, Joe was principally responsible for the worldwide introduction of the unique and highly-successful dynamic contact angle (DCA) family of instruments, and later established the North American market for Surface Measurement Systems’ successful DVS (dynamic vapor sorption) and iGC (inverse gas chromatography) instrument systems.
Andrew Graham, UK, Ireland and European Sales Consultant
Andrew has over 30 years of experience in the promotion and development of new technologies and products for industry and academia. Examples include DVS, the now almost universal technique for measuring water sorption isotherms of materials, and QCM-D, a highly popular quartz crystal microbalance instrument for characterising the physicochemical behaviour of surfaces. In 2011, he started the Oxford based Company ATG Scientific which specialises in assisting manufacturers of laboratory equipment find new markets and uses for innovative products in areas such as analytical chemistry, biopharmaceutics and materials science, including, of course, Gamlen Instruments’ Powder Compaction Analysers (PCA) for drug formulation and tablet manufacturing interests. Andrew has a BSc honours degree in metallurgy/materials science from Brunel University, West London. He is also a qualified Chartered Engineer and a Member of both the Institute of Materials and Academy of Pharmaceutical Sciences.
Agnes Gogognon, Lab Technician
Agnes Graduated with a BSc (Honours) Pharmaceutical Sciences Degree at the University of Greenwich, London. Agnes works as lab technician in R&D and productions, dispensing formulations of solid dosage forms, particularly tablets, troubleshooting for critical quality attributes and critical process parameters of powders and tablets, for the purpose of quality and safety of patients.
Henry Kafeman, Product Development Director
Henry has over 30 years of experience working in many engineering disciplines and has proved to be an invaluable asset. His ability to combine creative thinking with engineering excellence has resulted in a significant contribution to product development. His innovations include the unique patented rotating die for the Gamlen Instruments’ Powder Compaction Analysers (PCA), which measures detachment force in addition to compaction and ejection forces. He has worked with other members of the team and Microsoft Excel experts to develop the Gamlen Instruments’ “Dashboard” for basic data analysis and visualisation. For deeper understanding and for larger data sets, he has developed a MathWorks Matlab toolbox operating in conjunction with a SQL Server Database which is providing unique insights. Henry earned his MA in engineering at Queens’ College, University of Cambridge. His experience includes software engineering (support and troubleshooting as well as development), data analysis and visualisation. electronics/PCB design and simulation, embedded systems, databases, wireless communication, mechanical engineering and pneumatics.
Chi Chi Oparaeche, Laboratory and Production Manager
Chi Chi joined Gamlen Tableting in 2013. Her area of expertise is in the compaction and analysis of pharmaceutical excipients used in drug formulation. Based at our London laboratories, Chi Chi is Gamlen Tableting’s in-house specialist in using the Gamlen tablet press (Gamlen R series) and powder compaction analyser (PCA) for materials characterisation. Together with the laboratory team, Chi Chi oversees a range of Gamlen Tableting services including: sample testing, compaction studies of the behaviour of pharmaceutical materials, pre and post drug development and many more.
Chi Chi studied pharmacology at University College London and she is currently completing a PhD at the University of Greenwich in materials characterisation.
Dr Carole Malcolmson, Pharmaceutical and Quality Manager
Carole has worked within the pharmaceutical industry, academia and pharmaceutical consultancy for over 30 years. Her roles have included formulation and product development, clinical trial supplies, regulatory affairs and quality assurance for both small local companies and large multinationals within the pharmaceutical sector in the United Kingdom and New Zealand.
Irene Pinochi, Quality Assurance Manager
Irene is an expert in Quality Assurance with advanced understanding of Quality Management System Requirements. He focus on the ISO 9001 with knowledge of pharmaceutical requirements and GMP. Her experience performing compliance audit and maintain accurate records. Due to her past job experience she also has good knowledge of Medical Devices Directives and of ISO 13485. Irene is responsible to lead the improvement and developments of the QMS. Irene studied Quality Control of Medicines at University of Pisa.